ARCHIVES

FDA Asks Advisory Group To Define Role Of Single-Arm Studies In Four Applications

This article is from The Cancer Letter archive.

Vol. 35 No. 32 | September 4, 2009

Download PDF Visit The Full Archive

Related Articles

In Brief: Walter Lawrence, Reginald Ho Lead ACS; Henderson To Leave Dana-Farber for UCSF

November 22, 1991

NCI, HCFA Negotiate Demonstration Project as Congress, Advocates Exert Pressure

September 27, 1996

Cancer Control Contractors Severally Criticized In Merit Peer Review; Inadequate Reports Cited

May 28, 1976

Cancer Clinical Trials Approved By NCI Last Month Are Listed

October 25, 2002

NCI Cooperative Group Clinical Trials Approved

August 28, 2009

Taxol Recommended For Second Line Therapy In Platinum-Resistant Metastatic Ovarian Cancer

November 20, 1992